AgomAb Therapeutics NV (AGMB)
13.62
-0.59
(-4.15%)
USD |
NASDAQ |
Mar 06, 16:00
13.73
+0.11
(+0.81%)
After-Hours: 20:00
AgomAb Therapeutics EPS Diluted (Quarterly) : -0.2568 for Dec. 31, 2024
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Galapagos NV | 13.82 |
| UCB SA | -- |
| Ion Beam Applications SA | -- |
| Celyad Oncology SA | -- |
| Fagron NV | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.51M |
| Total Expenses (Quarterly) | 12.51M |